16 September 2013
5pm on 28 October 2013
This Fellowship is named in memory of Dr John Colebatch AO (1909 - 2005), to mark his contribution to the work of Cancer Council Victoria and his pioneering work in the field of paediatric haematology and clinical trial practice in Australia. The Fellowship has been made possible through funding provided by the Reg Geary Estate.
The Fellowship is intended to provide a means for identifying and developing clinical cancer researchers with the intellectual and personal qualities to take a leadership role in cancer research.
The Fellowship is available for a period of five years, commencing in early 2014, or as soon as possible thereafter, at a Victorian Hospital, University or Medical Research Institute.
The Fellowship is available to clinically qualified researchers, with a record of research experience equivalent to an MD or PhD. Applications from medical, nursing, and allied health practitioners* are encouraged. Clinical research can be interpreted broadly and includes translational, diagnostic, therapeutic and prognostic research.
Applicants should be mid-career researchers committed to pursuing a leadership role in cancer research. Senior, established investigators will not normally be considered.
Applicants must be Australian citizens, or be graduates from overseas with permanent Australian resident status.
Applicants should submit a 5-year budget proposal to a maximum of $1.5 million, including salary (commensurate with the percentage time commitment to the project), salary on-costs, direct and indirect research costs, infrastructure, travel etc.
Applicants need to have the explicit support of an appropriate host Victorian research institution for both their candidacy and their proposed research program. It's also essential that the candidate will have arranged for a mentor, under whose guidance the research program proposed will be conducted. The mentor will need to be a senior figure in cancer research.
It's anticipated that the successful applicant will hold a fractional clinical appointment with clinical sessions as appropriate.
The host institute will be required to provide the Fellow with at least 50% protected time for the research project (protected from clinical and administrative duties).
The host institution is required to enter into a funding agreement with Cancer Council Victoria. The conditions in the agreement will cover the standard research contract areas including acknowledgment, intellectual property, reporting requirements etc. Payments will be made quarterly in advance to the host institution.
Applications will be assessed against the following selection criteria:
The research proposal
The impact of the Fellowship
All applications will be assessed by an expert panel. Short-listed applicants will be required to attend an interview. Cancer Council Victoria reserves the right not to award the Fellowship.
The fellowship may not be held concurrently with other significant research salary support - for example, any NHMRC Fellowship or equivalent, or a research grant which specifically provides salary support for the applicant.
Additional funding for clinical sessions (eg part-time clinical appointment) is appropriate and expected.
Funding will not be granted to any researcher who is receiving or who is an applicant for funding from the tobacco industry or any of its agencies or subsidiaries.
Funding will be withdrawn without notice from any researcher or research for which an application is made to, or funding received from, the tobacco industry or any of its agencies or subsidiaries during the currency of the fellowship.
Applications are requested in the following format.
Please submit your application as a single pdf document to Karen.Sharp@cancervic.org.au.
Please name your document as follows, using your surname and initial: Colebatch_surname_initial.pdf.
Applications close at 5 pm on Monday 28 October 2013.
Enquiries and additional information available from
Head, Research Management Unit
Ph: (61 3) 9635 5100
Fax (61 3) 9635 5040
*Registration with AHPRA (Australian Health Practitioner Regulation Agency) is required.